TL;DR
Get beauty and skincare favorites delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Vytrus Biotech says it has quantified two forms of plant-derived PDRN in hair-care actives, extending its plant PDRN portfolio across skin, scalp and hair. The company reports findings from clinical, ex vivo and other studies, but the supplied report does not include sample sizes, protocols or full results.
Vytrus Biotech says it has quantified two forms of plant-derived PDRN in its hair-care actives, adding scalp and hair products to a portfolio it says already spans skin care. The company also reports study findings on hair density, scalp redness and curl performance, although the supplied account does not provide the study methods or participant numbers needed to evaluate the results independently.
The company describes Phyto-PDRN as DNA fragments that act at the cell surface, and ExoPDRN as PDRN naturally encapsulated within plant exosomes. Vytrus presents the two forms as a complementary approach, with activity at the cell surface and inside the cell. The source does not provide detailed experimental evidence for that mechanism.
For hair care, Vytrus says it quantified both forms in its actives for the first time. Capilia Longa, made from Curcuma longa stem cells, is described by the company as clinically proven to reduce hair loss and increase hair density. Vytrus says the results are consistent with scientific literature associating PDRN with hair growth; the supplied material does not identify the clinical trial or provide its measurements.
Elaya Renova, derived from Mediterranean olive stem cells, is reported to have reduced scalp redness versus placebo in a study. The company also cites an ex vivo curly-hair study: after one leave-on application, researchers recorded improved hydration, less combing effort and frizz, including under high humidity, and greater curl definition. These are company-reported findings, and the source gives no study design details or numerical results.
A Broader Plant PDRN Portfolio
The development broadens the claims and potential uses associated with plant-based PDRN beyond facial skin products to scalp comfort, hair density and textured-hair care. For cosmetic formulators, the company is presenting several actives that could support products for different needs, rather than a single ingredient positioned for one application.
The findings may draw attention from brands seeking plant-derived ingredients and evidence-backed product concepts. But the practical significance depends on evidence that is not included in the source: study size, controls, duration, measurement methods and whether the reported effects can be reproduced. The results should not be read as proof that the ingredients treat hair loss or a scalp condition.
Products Worth Considering
Therabody Theragun Mini 3rd Generation Massage Gun
Garmin Forerunner 55 GPS Running Smartwatch, Black
Blueair Blue Pure 511i Max Air Purifier
As an affiliate, we earn on qualifying purchases.
Skin Studies Behind the Hair Claims
The hair-care announcement builds on plant PDRN studies Vytrus presented in April for skin care, according to the source report. Its Centella Reversa combines Phyto-PDRN and ExoPDRN in a plant-cell secretome and is marketed for skin rejuvenation, regeneration and cellular DNA protection. Sensia Carota contains Phyto-PDRN and is positioned for sensitive skin, with the company reporting calming and redness-reduction benefits.
The company describes its expanded range as covering skin, scalp and hair, including skin soothing, hair-loss prevention, redensification, curly-hair care and scalp comfort. Those descriptions reflect product positioning and reported research; the source does not establish that every proposed benefit has the same level of clinical evidence.
“Phyto-PDRN and ExoPDRN are presented as a dual-action strategy working at the cell surface and inside the cell.”
— Vytrus Biotech, as described in the Cosmetics Business report
Study Details Still Missing
The source does not state when the studies were conducted, how many participants or samples were involved, or how outcomes were measured. It also omits effect sizes, study duration and full protocols. For the hair-loss and density claims, it is not clear whether the research was placebo-controlled or independently reviewed. The reported curl findings are explicitly ex vivo, so their relevance to everyday use on people is not established by the information provided.
The source also does not explain how the PDRN quantities were measured, whether the products were tested against comparable ingredients, or what concentrations were used. Vytrus’s claims should therefore be understood as company-reported findings, not as a complete independent assessment of efficacy.
Further Evidence and Formulator Details
Vytrus says formulators can contact the company for more information about its plant-based PDRN range. The next useful information would include published or otherwise accessible study protocols, sample sizes, numerical results and details on how the actives were tested. Those details would help brands and readers distinguish preliminary product research from evidence that supports broader performance claims.
No additional study release, regulatory decision or launch date is specified in the supplied report. Until further data are available, the reported results remain tied to Vytrus’s descriptions of its products and research.
Key Questions
What are Phyto-PDRN and ExoPDRN?
Vytrus describes Phyto-PDRN as plant-derived DNA fragments that act at the cell surface, and ExoPDRN as PDRN naturally encapsulated within plant exosomes. The company presents them as complementary forms.
What hair-care findings did Vytrus report?
The company says Capilia Longa was clinically shown to reduce hair loss and increase hair density. It also reports reduced scalp redness for Elaya Renova versus placebo and ex vivo improvements in hydration, combing, frizz and curl definition. The supplied account lacks study details for evaluating these claims.
Do the reported findings prove plant PDRN treats hair loss?
No. The source reports company-described cosmetic research, but does not provide enough trial information to assess the strength or generalizability of the evidence. The findings should not be treated as proof of a medical treatment.
What skin products are included in the portfolio?
Vytrus identifies Centella Reversa for skin rejuvenation and regeneration and Sensia Carota for sensitive-skin soothing and redness reduction. These benefits are described in the source as company claims.
Source: cosmeticsbusiness.com
